Skip to main content
. 2019 Nov 7;35(1):118–128. doi: 10.1080/14756366.2019.1687460

Table 4.

Inhibition of hAChE, and AChE- and self-induced Aβ1-42 aggregation by selected compounds.

  hAChE
Inhibition of Aβ1–42 aggregation (%)
Compd. IC50 (μM)a AChE-inducedb Self-inducedc
4c 0.16 ± 0.02 29.02 ± 2.06 30.67 ± 6.54
4d 0.57 ± 0.01 24.11 ± 3.04 26.01 ± 3.01
4e 0.38 ± 0.02 20.28 ± 2.21 25.82 ± 1.43
4f 1.21 ± 0.33 12.06 ± 3.18 20.35 ± 3.22
9a 0.76 ± 0.10 14.19 ± 2.85 33.36 ± 4.85
9b 0.39 ± 0.01 24.37 ± 3.03 35.29 ± 2.17
Donepezil 0.021 ± 0.001 26.16 ± 2.55
Tacrine 0.47 ± 0.03
Curcumin 37.27 ± 2.76

aThe 50% inhibitory concentration of hAChE (means ± SD of three experiments).

bInhibition of AChE-induced Aβ1–42 aggregation. The thioflavin-T fluorescence method was used, and the concentration of the tested inhibitor was 100 μM (means ± SD of three experiments).

cInhibition of self-induced Aβ1-42 aggregation. The thioflavin-T fluorescence method was used, and the measurements were carried out in the presence of 25 μM inhibitor (means ± SD of three experiments).